Health / Medical Topics |
P-glycoprotein Inhibitor HM30181AK
An inhibitor of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter P-glycoprotein (P-gp), with adjuvant activity. Upon oral administration, P-gp inhibitor HM30181AK selectively binds to and inhibits the multidrug resistance (MDR) efflux pump P-gp, which prevents the efflux of various chemotherapeutic agents from intestinal epithelial cells to the gastrointestinal tract. This leads to an increase in both oral bioavailability and therapeutic efficacy. P-gp prevents the intestinal uptake and intracellular accumulation of various cytotoxic agents. HM30181AK is not systemically absorbed. (NCI Thesaurus)
YOU MAY ALSO LIKE
A protein that pumps substances out of cells. Cancer cells that have too much p-glycoprotein may not be killed by anticancer…
A yellowish to pinkish colored, synthetic leaflet material. p-Chloro-o-toluidine is used in industry in the manufacture of azo dyes and is used…
An agent that inhibits P-cadherin (cdh3), with potential antineoplastic activity. PF-03732010 binds to and inhibits the activity of p-cadherin. Inhibition of the…
P-cadherin (829 aa, 91 kD) is a cell adhesion process protein that is encoded by the human CDH3 gene and has a…
A colorless, crystalline, solid aromatic amine that turns purple when exposed to air and emits toxic fumes when heated. p-Biphenylamine is used…
A radioactive form of the element phosphorus used in the treatment of cancer.